Health Canada, confirms the department's regulatory approval of Paxlovid, Pfizer's COVID-19 oral antivira

In a virtual news conference, Dr. Supriya Sharma, chief medical adviser with Health Canada, confirms the department's regulatory approval of Paxlovid, Pfizer's COVID-19 oral antiviral. The treatment is intended for adults with mild to moderate COVID-19 who are at high risk of becoming seriously ill. She is joined by Dr. Marc Berthiaume, director of the Bureau of Medical Science at Health Canada, Dr. Theresa Tam, Canada’s chief public health officer, and Dr. Howard Njoo, deputy chief public health officer.Become a supporter of this podcast: https://www.spreaker.com/podcast/depictions-media--4208927/support.